

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein maturation by protein folding (GO:0022417) | 6.69290580 |
| 2 | establishment of integrated proviral latency (GO:0075713) | 6.28939015 |
| 3 | establishment of viral latency (GO:0019043) | 5.87748519 |
| 4 | Golgi transport vesicle coating (GO:0048200) | 4.97077513 |
| 5 | COPI coating of Golgi vesicle (GO:0048205) | 4.97077513 |
| 6 | proteasome assembly (GO:0043248) | 4.74724258 |
| 7 | DNA unwinding involved in DNA replication (GO:0006268) | 4.60345751 |
| 8 | mitotic nuclear envelope reassembly (GO:0007084) | 4.52780079 |
| 9 | nuclear envelope reassembly (GO:0031468) | 4.52780079 |
| 10 | ribosome assembly (GO:0042255) | 4.47192196 |
| 11 | gonadal mesoderm development (GO:0007506) | 4.16893012 |
| 12 | formation of translation preinitiation complex (GO:0001731) | 4.04730186 |
| 13 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.99962742 |
| 14 | ribosomal large subunit biogenesis (GO:0042273) | 3.82965037 |
| 15 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.80667589 |
| 16 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.77153683 |
| 17 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.74113305 |
| 18 | protein retention in ER lumen (GO:0006621) | 3.71550189 |
| 19 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.70181715 |
| 20 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.69600636 |
| 21 | extracellular fibril organization (GO:0043206) | 3.66798254 |
| 22 | negative regulation of ligase activity (GO:0051352) | 3.64932103 |
| 23 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.64932103 |
| 24 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.62524805 |
| 25 | regulation of mitotic spindle organization (GO:0060236) | 3.60540937 |
| 26 | muscle cell migration (GO:0014812) | 3.59460973 |
| 27 | galactose catabolic process (GO:0019388) | 3.51995067 |
| 28 | regulation of metalloenzyme activity (GO:0048552) | 3.51378341 |
| 29 | membrane raft organization (GO:0031579) | 3.50497562 |
| 30 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.48913693 |
| 31 | morphogenesis of an endothelium (GO:0003159) | 3.48841934 |
| 32 | endothelial tube morphogenesis (GO:0061154) | 3.48841934 |
| 33 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 3.47915659 |
| 34 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.46370703 |
| 35 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.45597813 |
| 36 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.37980222 |
| 37 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.37283847 |
| 38 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.35043354 |
| 39 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.35043354 |
| 40 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.34785012 |
| 41 | positive regulation of ligase activity (GO:0051351) | 3.30349524 |
| 42 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.28365497 |
| 43 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.28150683 |
| 44 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.28150683 |
| 45 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.28150683 |
| 46 | response to gravity (GO:0009629) | 3.26250073 |
| 47 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.26055538 |
| 48 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.26055538 |
| 49 | regulation of mitochondrial translation (GO:0070129) | 3.18974063 |
| 50 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.17599011 |
| 51 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.11404989 |
| 52 | regulation of spindle organization (GO:0090224) | 3.07527171 |
| 53 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.06479846 |
| 54 | DNA strand elongation (GO:0022616) | 3.05680910 |
| 55 | proline biosynthetic process (GO:0006561) | 3.05400418 |
| 56 | positive regulation of actin filament depolymerization (GO:0030836) | 3.05343739 |
| 57 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.03911818 |
| 58 | AMP metabolic process (GO:0046033) | 3.02816637 |
| 59 | fibril organization (GO:0097435) | 3.01973828 |
| 60 | protein targeting to mitochondrion (GO:0006626) | 3.00479696 |
| 61 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.99436280 |
| 62 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.98724505 |
| 63 | mitotic chromosome condensation (GO:0007076) | 2.98666902 |
| 64 | mitotic sister chromatid segregation (GO:0000070) | 2.98567579 |
| 65 | GDP-mannose metabolic process (GO:0019673) | 2.93841704 |
| 66 | mitotic metaphase plate congression (GO:0007080) | 2.92313434 |
| 67 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.91993872 |
| 68 | regulation of ligase activity (GO:0051340) | 2.90226491 |
| 69 | lipopolysaccharide metabolic process (GO:0008653) | 2.88254805 |
| 70 | actin filament depolymerization (GO:0030042) | 2.87391660 |
| 71 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.85788839 |
| 72 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.84356515 |
| 73 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.82073377 |
| 74 | ribosomal small subunit assembly (GO:0000028) | 2.79692130 |
| 75 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 2.78976218 |
| 76 | regulation of translational fidelity (GO:0006450) | 2.78833998 |
| 77 | galactose metabolic process (GO:0006012) | 2.78450865 |
| 78 | telomere maintenance via recombination (GO:0000722) | 2.75334323 |
| 79 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 2.74535179 |
| 80 | cellular copper ion homeostasis (GO:0006878) | 2.73203465 |
| 81 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.72248231 |
| 82 | ribosome biogenesis (GO:0042254) | 2.68279492 |
| 83 | mitotic recombination (GO:0006312) | 2.67641842 |
| 84 | ATP synthesis coupled proton transport (GO:0015986) | 2.67063586 |
| 85 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.67063586 |
| 86 | heterochromatin organization (GO:0070828) | 2.66780264 |
| 87 | establishment of protein localization to mitochondrion (GO:0072655) | 2.66648774 |
| 88 | 7-methylguanosine mRNA capping (GO:0006370) | 2.65058502 |
| 89 | mitotic nuclear envelope disassembly (GO:0007077) | 2.64235466 |
| 90 | protein localization to mitochondrion (GO:0070585) | 2.62829672 |
| 91 | glycolytic process (GO:0006096) | 2.61712685 |
| 92 | fibrinolysis (GO:0042730) | 2.59822104 |
| 93 | chaperone-mediated protein transport (GO:0072321) | 2.58204097 |
| 94 | metaphase plate congression (GO:0051310) | 2.58096970 |
| 95 | negative regulation of protein ubiquitination (GO:0031397) | 2.57743130 |
| 96 | heme biosynthetic process (GO:0006783) | 2.56553067 |
| 97 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.56512590 |
| 98 | RNA capping (GO:0036260) | 2.56285705 |
| 99 | 7-methylguanosine RNA capping (GO:0009452) | 2.56285705 |
| 100 | nucleoside transmembrane transport (GO:1901642) | 2.56105110 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.94416553 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.51912235 |
| 3 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.17609422 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.06006959 |
| 5 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.05253053 |
| 6 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.98989545 |
| 7 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.87971618 |
| 8 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.85675866 |
| 9 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.79095380 |
| 10 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.77013150 |
| 11 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.67080812 |
| 12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.53133118 |
| 13 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.53046127 |
| 14 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.50034001 |
| 15 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.49777579 |
| 16 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 2.35442181 |
| 17 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.29594057 |
| 18 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.25151388 |
| 19 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.22417591 |
| 20 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.20914921 |
| 21 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.16988869 |
| 22 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.14685947 |
| 23 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.12198388 |
| 24 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.11207700 |
| 25 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.10921742 |
| 26 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.09381673 |
| 27 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.05313387 |
| 28 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.04190763 |
| 29 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.00219423 |
| 30 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.97453498 |
| 31 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.94322104 |
| 32 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.90711931 |
| 33 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.89149178 |
| 34 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.85648161 |
| 35 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.74857343 |
| 36 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.71749357 |
| 37 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.67300406 |
| 38 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.63964462 |
| 39 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.63327421 |
| 40 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.61269889 |
| 41 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.61257097 |
| 42 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.59057975 |
| 43 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.58410933 |
| 44 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.57243118 |
| 45 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.53317911 |
| 46 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.51195097 |
| 47 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.50888761 |
| 48 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.49858354 |
| 49 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.49779242 |
| 50 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.48776975 |
| 51 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.45678262 |
| 52 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.43441611 |
| 53 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.43338452 |
| 54 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.42859945 |
| 55 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42690709 |
| 56 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42393586 |
| 57 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.41381620 |
| 58 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.39459125 |
| 59 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.36929114 |
| 60 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.36421004 |
| 61 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.36335523 |
| 62 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.36134285 |
| 63 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.34644297 |
| 64 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.34119629 |
| 65 | ATF3_27146783_Chip-Seq_COLON_Human | 1.30639695 |
| 66 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.29679140 |
| 67 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.27946761 |
| 68 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.27701902 |
| 69 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.27191212 |
| 70 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.26785012 |
| 71 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.26420282 |
| 72 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.26352630 |
| 73 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.25567732 |
| 74 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.25292195 |
| 75 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.24632188 |
| 76 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.23519184 |
| 77 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.21303270 |
| 78 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.21196843 |
| 79 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.19413770 |
| 80 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.18844578 |
| 81 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.18208654 |
| 82 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.17187105 |
| 83 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.15882092 |
| 84 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.15631770 |
| 85 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.12209109 |
| 86 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11909298 |
| 87 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.10954805 |
| 88 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.09962874 |
| 89 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.09513921 |
| 90 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.08761054 |
| 91 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.07686565 |
| 92 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07684859 |
| 93 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.05866221 |
| 94 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.05571008 |
| 95 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.03942511 |
| 96 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.03942511 |
| 97 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.03231396 |
| 98 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.96249571 |
| 99 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.94838976 |
| 100 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.94166769 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003191_abnormal_cellular_cholesterol | 3.55170800 |
| 2 | MP0003123_paternal_imprinting | 3.54434403 |
| 3 | MP0002877_abnormal_melanocyte_morpholog | 3.35489460 |
| 4 | MP0003950_abnormal_plasma_membrane | 2.97502370 |
| 5 | MP0009697_abnormal_copulation | 2.75872905 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 2.72562844 |
| 7 | MP0004957_abnormal_blastocyst_morpholog | 2.68915787 |
| 8 | MP0003786_premature_aging | 2.68780499 |
| 9 | MP0003693_abnormal_embryo_hatching | 2.63913221 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.50933069 |
| 11 | MP0000750_abnormal_muscle_regeneration | 2.41757312 |
| 12 | MP0000751_myopathy | 2.36809358 |
| 13 | MP0003111_abnormal_nucleus_morphology | 2.28421499 |
| 14 | MP0008007_abnormal_cellular_replicative | 2.27138195 |
| 15 | MP0005257_abnormal_intraocular_pressure | 2.26240636 |
| 16 | MP0010030_abnormal_orbit_morphology | 2.24514367 |
| 17 | MP0000749_muscle_degeneration | 2.18788293 |
| 18 | MP0005451_abnormal_body_composition | 2.18444598 |
| 19 | MP0003077_abnormal_cell_cycle | 2.14410679 |
| 20 | MP0010094_abnormal_chromosome_stability | 2.11901202 |
| 21 | MP0008058_abnormal_DNA_repair | 2.09415651 |
| 22 | MP0003656_abnormal_erythrocyte_physiolo | 2.08813377 |
| 23 | MP0001853_heart_inflammation | 2.04632946 |
| 24 | MP0002332_abnormal_exercise_endurance | 2.03537755 |
| 25 | MP0008932_abnormal_embryonic_tissue | 2.00567489 |
| 26 | MP0004272_abnormal_basement_membrane | 1.96157745 |
| 27 | MP0005360_urolithiasis | 1.95878844 |
| 28 | MP0004147_increased_porphyrin_level | 1.89584092 |
| 29 | MP0005165_increased_susceptibility_to | 1.88878037 |
| 30 | MP0003186_abnormal_redox_activity | 1.74046049 |
| 31 | MP0003566_abnormal_cell_adhesion | 1.71578688 |
| 32 | MP0009840_abnormal_foam_cell | 1.71127025 |
| 33 | MP0000858_altered_metastatic_potential | 1.70834501 |
| 34 | MP0005083_abnormal_biliary_tract | 1.66242552 |
| 35 | MP0005330_cardiomyopathy | 1.64911486 |
| 36 | MP0001542_abnormal_bone_strength | 1.62971533 |
| 37 | MP0004510_myositis | 1.58737666 |
| 38 | MP0003315_abnormal_perineum_morphology | 1.58703761 |
| 39 | MP0000358_abnormal_cell_content/ | 1.55435960 |
| 40 | MP0006036_abnormal_mitochondrial_physio | 1.55367287 |
| 41 | MP0003718_maternal_effect | 1.45267615 |
| 42 | MP0008775_abnormal_heart_ventricle | 1.41813643 |
| 43 | MP0000343_altered_response_to | 1.40939154 |
| 44 | MP0006035_abnormal_mitochondrial_morpho | 1.37515022 |
| 45 | MP0005408_hypopigmentation | 1.35074725 |
| 46 | MP0000350_abnormal_cell_proliferation | 1.32512092 |
| 47 | MP0002060_abnormal_skin_morphology | 1.30933802 |
| 48 | MP0000647_abnormal_sebaceous_gland | 1.28721976 |
| 49 | MP0005670_abnormal_white_adipose | 1.25877924 |
| 50 | MP0001730_embryonic_growth_arrest | 1.21369398 |
| 51 | MP0005464_abnormal_platelet_physiology | 1.20993233 |
| 52 | MP0003075_altered_response_to | 1.19878413 |
| 53 | MP0004233_abnormal_muscle_weight | 1.16000050 |
| 54 | MP0008995_early_reproductive_senescence | 1.15753854 |
| 55 | MP0001243_abnormal_dermal_layer | 1.11172729 |
| 56 | MP0000516_abnormal_urinary_system | 1.11089006 |
| 57 | MP0005367_renal/urinary_system_phenotyp | 1.11089006 |
| 58 | MP0002080_prenatal_lethality | 1.09166061 |
| 59 | MP0009780_abnormal_chondrocyte_physiolo | 1.07968886 |
| 60 | MP0005197_abnormal_uvea_morphology | 1.07861120 |
| 61 | MP0008260_abnormal_autophagy | 1.01835771 |
| 62 | MP0000313_abnormal_cell_death | 1.01559758 |
| 63 | MP0009333_abnormal_splenocyte_physiolog | 1.00290705 |
| 64 | MP0000747_muscle_weakness | 0.99841234 |
| 65 | MP0002019_abnormal_tumor_incidence | 0.99799748 |
| 66 | MP0005501_abnormal_skin_physiology | 0.97201286 |
| 67 | MP0005164_abnormal_response_to | 0.96643871 |
| 68 | MP0001697_abnormal_embryo_size | 0.93634819 |
| 69 | MP0001299_abnormal_eye_distance/ | 0.87349718 |
| 70 | MP0003705_abnormal_hypodermis_morpholog | 0.86985726 |
| 71 | MP0003221_abnormal_cardiomyocyte_apopto | 0.85539577 |
| 72 | MP0001545_abnormal_hematopoietic_system | 0.85075504 |
| 73 | MP0005397_hematopoietic_system_phenotyp | 0.85075504 |
| 74 | MP0008438_abnormal_cutaneous_collagen | 0.84852629 |
| 75 | MP0003984_embryonic_growth_retardation | 0.82122025 |
| 76 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.81661472 |
| 77 | MP0005384_cellular_phenotype | 0.80927937 |
| 78 | MP0001216_abnormal_epidermal_layer | 0.80271222 |
| 79 | MP0002269_muscular_atrophy | 0.77992562 |
| 80 | MP0002796_impaired_skin_barrier | 0.77190531 |
| 81 | MP0005380_embryogenesis_phenotype | 0.77173293 |
| 82 | MP0001672_abnormal_embryogenesis/_devel | 0.77173293 |
| 83 | MP0002088_abnormal_embryonic_growth/wei | 0.74837700 |
| 84 | MP0001881_abnormal_mammary_gland | 0.72598864 |
| 85 | MP0000609_abnormal_liver_physiology | 0.72587310 |
| 86 | MP0002177_abnormal_outer_ear | 0.71671363 |
| 87 | MP0000762_abnormal_tongue_morphology | 0.69785075 |
| 88 | MP0005621_abnormal_cell_physiology | 0.69590830 |
| 89 | MP0000759_abnormal_skeletal_muscle | 0.69524028 |
| 90 | MP0002972_abnormal_cardiac_muscle | 0.68852998 |
| 91 | MP0002210_abnormal_sex_determination | 0.66513233 |
| 92 | MP0003453_abnormal_keratinocyte_physiol | 0.66191138 |
| 93 | MP0005266_abnormal_metabolism | 0.65019144 |
| 94 | MP0004185_abnormal_adipocyte_glucose | 0.63805182 |
| 95 | MP0003943_abnormal_hepatobiliary_system | 0.63438728 |
| 96 | MP0002086_abnormal_extraembryonic_tissu | 0.63392547 |
| 97 | MP0005376_homeostasis/metabolism_phenot | 0.62099277 |
| 98 | MP0005023_abnormal_wound_healing | 0.61543595 |
| 99 | MP0003436_decreased_susceptibility_to | 0.61148597 |
| 100 | MP0008875_abnormal_xenobiotic_pharmacok | 0.60360879 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Reduced subcutaneous adipose tissue (HP:0003758) | 4.42781254 |
| 2 | Abnormal gallbladder physiology (HP:0012438) | 4.40062092 |
| 3 | Cholecystitis (HP:0001082) | 4.40062092 |
| 4 | Upper limb muscle weakness (HP:0003484) | 4.24934947 |
| 5 | Glucose intolerance (HP:0000833) | 4.00933725 |
| 6 | Amyloidosis (HP:0011034) | 3.72179145 |
| 7 | Increased serum pyruvate (HP:0003542) | 3.67008695 |
| 8 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.60514688 |
| 9 | Osteolytic defects of the hand bones (HP:0009699) | 3.60514688 |
| 10 | Abnormality of glycolysis (HP:0004366) | 3.57750099 |
| 11 | Adrenal hypoplasia (HP:0000835) | 3.55636373 |
| 12 | Entropion (HP:0000621) | 3.43623183 |
| 13 | Premature rupture of membranes (HP:0001788) | 3.28093726 |
| 14 | Short nail (HP:0001799) | 3.14840763 |
| 15 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.14714239 |
| 16 | Acute necrotizing encephalopathy (HP:0006965) | 3.13245587 |
| 17 | Delayed CNS myelination (HP:0002188) | 2.99972601 |
| 18 | Hepatocellular necrosis (HP:0001404) | 2.99651340 |
| 19 | Rough bone trabeculation (HP:0100670) | 2.97768346 |
| 20 | Vertebral compression fractures (HP:0002953) | 2.90147766 |
| 21 | Reduced antithrombin III activity (HP:0001976) | 2.88724503 |
| 22 | Increased connective tissue (HP:0009025) | 2.87494064 |
| 23 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.86458722 |
| 24 | Type I transferrin isoform profile (HP:0003642) | 2.84077919 |
| 25 | Microglossia (HP:0000171) | 2.83033745 |
| 26 | Acute encephalopathy (HP:0006846) | 2.81139481 |
| 27 | Mitochondrial inheritance (HP:0001427) | 2.79562521 |
| 28 | Distal lower limb muscle weakness (HP:0009053) | 2.77064059 |
| 29 | Distal lower limb amyotrophy (HP:0008944) | 2.75581422 |
| 30 | Hypertensive crisis (HP:0100735) | 2.71277529 |
| 31 | Hepatic necrosis (HP:0002605) | 2.64363275 |
| 32 | Hand muscle atrophy (HP:0009130) | 2.62327779 |
| 33 | Orthostatic hypotension (HP:0001278) | 2.59361169 |
| 34 | Fatigue (HP:0012378) | 2.57171256 |
| 35 | Abnormal glucose tolerance (HP:0001952) | 2.53527954 |
| 36 | Shoulder girdle muscle weakness (HP:0003547) | 2.50752926 |
| 37 | Secondary amenorrhea (HP:0000869) | 2.49169301 |
| 38 | Increased CSF lactate (HP:0002490) | 2.46570253 |
| 39 | Myocardial infarction (HP:0001658) | 2.46411734 |
| 40 | Progressive macrocephaly (HP:0004481) | 2.45120717 |
| 41 | Insulin resistance (HP:0000855) | 2.42156731 |
| 42 | Exercise intolerance (HP:0003546) | 2.40654282 |
| 43 | Sparse eyelashes (HP:0000653) | 2.34846480 |
| 44 | Pelvic girdle muscle weakness (HP:0003749) | 2.34314365 |
| 45 | Abnormal autonomic nervous system physiology (HP:0012332) | 2.34032383 |
| 46 | Renal Fanconi syndrome (HP:0001994) | 2.33131642 |
| 47 | Abnormal platelet function (HP:0011869) | 2.30919705 |
| 48 | Impaired platelet aggregation (HP:0003540) | 2.30919705 |
| 49 | Abnormality of the umbilical cord (HP:0010881) | 2.30845304 |
| 50 | Upper limb amyotrophy (HP:0009129) | 2.29654900 |
| 51 | Distal upper limb amyotrophy (HP:0007149) | 2.29654900 |
| 52 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.27826854 |
| 53 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.27715574 |
| 54 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.27715574 |
| 55 | Abnormal protein glycosylation (HP:0012346) | 2.27715574 |
| 56 | Abnormal glycosylation (HP:0012345) | 2.27715574 |
| 57 | Vascular calcification (HP:0004934) | 2.25331356 |
| 58 | Abnormal trabecular bone morphology (HP:0100671) | 2.22693779 |
| 59 | Increased serum lactate (HP:0002151) | 2.22052763 |
| 60 | Cholelithiasis (HP:0001081) | 2.20984386 |
| 61 | Decreased subcutaneous fat (HP:0001002) | 2.17648246 |
| 62 | Insomnia (HP:0100785) | 2.17307288 |
| 63 | Ileus (HP:0002595) | 2.16585255 |
| 64 | Increased hepatocellular lipid droplets (HP:0006565) | 2.15717426 |
| 65 | Abnormal hemoglobin (HP:0011902) | 2.13612377 |
| 66 | Limb-girdle muscle atrophy (HP:0003797) | 2.12742571 |
| 67 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.12046306 |
| 68 | Abnormality of alanine metabolism (HP:0010916) | 2.12046306 |
| 69 | Hyperalaninemia (HP:0003348) | 2.12046306 |
| 70 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.11649373 |
| 71 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.11649373 |
| 72 | Difficulty climbing stairs (HP:0003551) | 2.11508731 |
| 73 | Hepatosplenomegaly (HP:0001433) | 2.11110500 |
| 74 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.08728811 |
| 75 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.08728811 |
| 76 | Hepatocellular carcinoma (HP:0001402) | 2.01094748 |
| 77 | Progressive muscle weakness (HP:0003323) | 2.00005443 |
| 78 | Palpitations (HP:0001962) | 1.99950057 |
| 79 | Hyperbilirubinemia (HP:0002904) | 1.99726575 |
| 80 | Lactic acidosis (HP:0003128) | 1.99640172 |
| 81 | Spastic paraparesis (HP:0002313) | 1.99460344 |
| 82 | Achilles tendon contracture (HP:0001771) | 1.98989871 |
| 83 | Axonal loss (HP:0003447) | 1.97227763 |
| 84 | Increased intramyocellular lipid droplets (HP:0012240) | 1.96406170 |
| 85 | Proximal placement of thumb (HP:0009623) | 1.96203135 |
| 86 | Deviation of the thumb (HP:0009603) | 1.94805374 |
| 87 | Reticulocytosis (HP:0001923) | 1.94730696 |
| 88 | Hypokinesia (HP:0002375) | 1.93441559 |
| 89 | Hypergonadotropic hypogonadism (HP:0000815) | 1.93352105 |
| 90 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.92950203 |
| 91 | Conjugated hyperbilirubinemia (HP:0002908) | 1.91834893 |
| 92 | Cerebral edema (HP:0002181) | 1.91743715 |
| 93 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.91732335 |
| 94 | Testicular atrophy (HP:0000029) | 1.91368216 |
| 95 | Ureteral duplication (HP:0000073) | 1.89876575 |
| 96 | Abnormal gallbladder morphology (HP:0012437) | 1.89402013 |
| 97 | Male infertility (HP:0003251) | 1.88637806 |
| 98 | Onycholysis (HP:0001806) | 1.88338127 |
| 99 | Respiratory failure (HP:0002878) | 1.87243055 |
| 100 | Emotional lability (HP:0000712) | 1.86369059 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 5.27374663 |
| 2 | TESK2 | 4.24108772 |
| 3 | VRK2 | 4.23752799 |
| 4 | TESK1 | 4.11106233 |
| 5 | MST1R | 3.80081323 |
| 6 | EPHA2 | 3.55978214 |
| 7 | LIMK1 | 3.34408403 |
| 8 | BUB1 | 3.20103080 |
| 9 | IRAK3 | 2.77391507 |
| 10 | ARAF | 2.49879946 |
| 11 | LMTK2 | 2.20344131 |
| 12 | EIF2AK1 | 2.10293865 |
| 13 | NEK1 | 1.95985590 |
| 14 | SRPK1 | 1.89152952 |
| 15 | PAK4 | 1.85136329 |
| 16 | PIM2 | 1.81921405 |
| 17 | SCYL2 | 1.78773611 |
| 18 | ERN1 | 1.70453017 |
| 19 | STK10 | 1.69856387 |
| 20 | MET | 1.58852855 |
| 21 | MOS | 1.56728242 |
| 22 | TAOK2 | 1.44834233 |
| 23 | DAPK1 | 1.42224527 |
| 24 | CCNB1 | 1.41628174 |
| 25 | ERBB4 | 1.32187557 |
| 26 | MST4 | 1.31829051 |
| 27 | BRAF | 1.21408165 |
| 28 | BRSK1 | 1.19831896 |
| 29 | MAP2K7 | 1.19348478 |
| 30 | BCKDK | 1.13661999 |
| 31 | BMX | 1.09991755 |
| 32 | MAP3K12 | 1.08694014 |
| 33 | ABL2 | 1.07111602 |
| 34 | STK16 | 1.03549921 |
| 35 | MAPKAPK3 | 1.00369781 |
| 36 | ILK | 1.00096306 |
| 37 | CDK8 | 0.99510944 |
| 38 | ICK | 0.99093248 |
| 39 | PTK2 | 0.95277007 |
| 40 | VRK1 | 0.92916210 |
| 41 | EIF2AK3 | 0.92654808 |
| 42 | RAF1 | 0.90420349 |
| 43 | AURKA | 0.89718956 |
| 44 | PAK1 | 0.89207769 |
| 45 | LRRK2 | 0.84738152 |
| 46 | PRPF4B | 0.82686700 |
| 47 | MAP3K8 | 0.81860877 |
| 48 | PBK | 0.80339972 |
| 49 | TTK | 0.79552426 |
| 50 | PHKG1 | 0.78016862 |
| 51 | PHKG2 | 0.78016862 |
| 52 | CDC7 | 0.76015137 |
| 53 | TSSK6 | 0.74432878 |
| 54 | NEK2 | 0.74112448 |
| 55 | KDR | 0.69779796 |
| 56 | AURKB | 0.68723021 |
| 57 | PDK2 | 0.66923929 |
| 58 | WEE1 | 0.65548951 |
| 59 | PTK2B | 0.63247169 |
| 60 | CDK7 | 0.63235197 |
| 61 | PLK1 | 0.62455550 |
| 62 | NME1 | 0.62415552 |
| 63 | EIF2AK2 | 0.60971629 |
| 64 | RPS6KB2 | 0.57002228 |
| 65 | CLK1 | 0.56766360 |
| 66 | PRKCI | 0.56098260 |
| 67 | ERBB3 | 0.55827062 |
| 68 | CSNK1G3 | 0.54698932 |
| 69 | BRSK2 | 0.52462101 |
| 70 | PLK4 | 0.50978650 |
| 71 | TBK1 | 0.49928974 |
| 72 | PLK3 | 0.49260060 |
| 73 | CSNK1A1L | 0.44967735 |
| 74 | HIPK2 | 0.43843163 |
| 75 | SIK3 | 0.41233883 |
| 76 | CHEK2 | 0.39949625 |
| 77 | CSNK2A2 | 0.39569282 |
| 78 | CDK14 | 0.38640612 |
| 79 | TGFBR2 | 0.38332370 |
| 80 | CDK18 | 0.37122893 |
| 81 | EPHB1 | 0.36767963 |
| 82 | CDK11A | 0.36518217 |
| 83 | MYLK | 0.35733918 |
| 84 | BMPR2 | 0.35580726 |
| 85 | CDK15 | 0.35306493 |
| 86 | MAPKAPK2 | 0.34272976 |
| 87 | DAPK3 | 0.31996810 |
| 88 | MAP3K3 | 0.31076770 |
| 89 | MAP3K11 | 0.28288307 |
| 90 | MAP2K3 | 0.28288091 |
| 91 | MAP3K6 | 0.26482935 |
| 92 | CHEK1 | 0.25342347 |
| 93 | STK4 | 0.24196570 |
| 94 | ATR | 0.24023112 |
| 95 | RPS6KA5 | 0.22934757 |
| 96 | PTK6 | 0.22391691 |
| 97 | GRK7 | 0.22197781 |
| 98 | GRK5 | 0.21850527 |
| 99 | CSNK1G1 | 0.21351908 |
| 100 | EPHB2 | 0.21253736 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.82471682 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.71376806 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 2.96552919 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 2.93412832 |
| 5 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.60360627 |
| 6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.50990428 |
| 7 | RNA polymerase_Homo sapiens_hsa03020 | 2.38426478 |
| 8 | Base excision repair_Homo sapiens_hsa03410 | 2.36281367 |
| 9 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.32766334 |
| 10 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.31792409 |
| 11 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.25880638 |
| 12 | Parkinsons disease_Homo sapiens_hsa05012 | 2.16492366 |
| 13 | Sulfur relay system_Homo sapiens_hsa04122 | 2.14961415 |
| 14 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.11591788 |
| 15 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.05002704 |
| 16 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.02336190 |
| 17 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 2.01855573 |
| 18 | Huntingtons disease_Homo sapiens_hsa05016 | 1.92398405 |
| 19 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.91254730 |
| 20 | Homologous recombination_Homo sapiens_hsa03440 | 1.88609785 |
| 21 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.78719121 |
| 22 | Alzheimers disease_Homo sapiens_hsa05010 | 1.69302794 |
| 23 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.66897699 |
| 24 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.63819073 |
| 25 | Galactose metabolism_Homo sapiens_hsa00052 | 1.59540544 |
| 26 | Carbon metabolism_Homo sapiens_hsa01200 | 1.58502620 |
| 27 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.57857714 |
| 28 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.54739844 |
| 29 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.54554722 |
| 30 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.53498845 |
| 31 | Spliceosome_Homo sapiens_hsa03040 | 1.52922654 |
| 32 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.51774686 |
| 33 | RNA transport_Homo sapiens_hsa03013 | 1.48572493 |
| 34 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.47441859 |
| 35 | Other glycan degradation_Homo sapiens_hsa00511 | 1.28254044 |
| 36 | Cell cycle_Homo sapiens_hsa04110 | 1.19250831 |
| 37 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.13574459 |
| 38 | Purine metabolism_Homo sapiens_hsa00230 | 1.12720780 |
| 39 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.11224900 |
| 40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.09560982 |
| 41 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.07888578 |
| 42 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.01998438 |
| 43 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.00931406 |
| 44 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.00020478 |
| 45 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.99266340 |
| 46 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.98950410 |
| 47 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.98879216 |
| 48 | Protein export_Homo sapiens_hsa03060 | 0.92875604 |
| 49 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.92390922 |
| 50 | Basal transcription factors_Homo sapiens_hsa03022 | 0.81505697 |
| 51 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.79987225 |
| 52 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.79297714 |
| 53 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.79257429 |
| 54 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.77947759 |
| 55 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.76792121 |
| 56 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.75493591 |
| 57 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.72057319 |
| 58 | Metabolic pathways_Homo sapiens_hsa01100 | 0.71302714 |
| 59 | Shigellosis_Homo sapiens_hsa05131 | 0.70024376 |
| 60 | Apoptosis_Homo sapiens_hsa04210 | 0.64190507 |
| 61 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.64094197 |
| 62 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.62721360 |
| 63 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.58153906 |
| 64 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.56856812 |
| 65 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.56304820 |
| 66 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.54902970 |
| 67 | Salivary secretion_Homo sapiens_hsa04970 | 0.54848330 |
| 68 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.52684809 |
| 69 | RNA degradation_Homo sapiens_hsa03018 | 0.52602108 |
| 70 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.52073569 |
| 71 | Bladder cancer_Homo sapiens_hsa05219 | 0.49840449 |
| 72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.48394342 |
| 73 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.46970001 |
| 74 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.45569418 |
| 75 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.45380620 |
| 76 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.45241791 |
| 77 | Lysosome_Homo sapiens_hsa04142 | 0.42961680 |
| 78 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.42121650 |
| 79 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.41957592 |
| 80 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.40632731 |
| 81 | Thyroid cancer_Homo sapiens_hsa05216 | 0.40022628 |
| 82 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.37584271 |
| 83 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.35579289 |
| 84 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.34233135 |
| 85 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.32664836 |
| 86 | Endocytosis_Homo sapiens_hsa04144 | 0.29009003 |
| 87 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.26218910 |
| 88 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.25472304 |
| 89 | Salmonella infection_Homo sapiens_hsa05132 | 0.24683412 |
| 90 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.24115672 |
| 91 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.23761842 |
| 92 | Legionellosis_Homo sapiens_hsa05134 | 0.22537040 |
| 93 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.20868320 |
| 94 | Peroxisome_Homo sapiens_hsa04146 | 0.20747100 |
| 95 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.20656992 |
| 96 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.17793404 |
| 97 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.17471847 |
| 98 | Mineral absorption_Homo sapiens_hsa04978 | 0.17279403 |
| 99 | HTLV-I infection_Homo sapiens_hsa05166 | 0.17198640 |
| 100 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.16747200 |

